Cargando…
Repurposing of anti-lung cancer drugs as multi-target inhibitors of SARS-CoV-2 proteins: An insight from molecular docking and MD-simulation study
Herein we have selected seventeen anti-lung cancer drugs to screen against Mpro, PLpro and spike glycoproteins of SARS-CoV-2to ascertain the potential therapeutic agent against COVID-19. ADMET profiling were employed to evaluate their pharmacokinetic properties. Molecular docking studies revealed th...
Autores principales: | Reza, Rahimasoom, Dutta, Tanmoy, Baildya, Nabajyoti, Ghosh, Narendra Nath, Khan, Abdul Ashik, Das, Rajesh Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174081/ https://www.ncbi.nlm.nih.gov/pubmed/35690231 http://dx.doi.org/10.1016/j.micpath.2022.105615 |
Ejemplares similares
-
Inhibitory effect of anti-HIV compounds extracted from Indian medicinal plants to retard the replication and transcription process of SARS-CoV-2: an insight from molecular docking and MD-simulation studies
por: Dutta, Tanmoy, et al.
Publicado: (2021) -
Screening of potential drug from Azadirachta Indica (Neem) extracts for SARS-CoV-2: An insight from molecular docking and MD-simulation studies
por: Baildya, Nabajyoti, et al.
Publicado: (2021) -
Inhibitory efficiency of potential drugs against SARS-CoV-2 by blocking human angiotensin converting enzyme-2: Virtual screening and molecular dynamics study
por: Khan, Abdul Ashik, et al.
Publicado: (2021) -
Inhibitory capacity of chloroquine against SARS-COV-2 by effective binding with angiotensin converting enzyme-2 receptor: An insight from molecular docking and MD-simulation studies
por: Baildya, Nabajyoti, et al.
Publicado: (2021) -
Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies
por: Baildya, Nabajyoti, et al.
Publicado: (2020)